E
Sell
9/17/2024Downgrade
ZYUS Life Sciences Corporation (ZYUS.V) was downgraded to E+ from D- on 9/17/2024 due to a substantial decline in the growth index, solvency index and valuation index. The quick ratio declined from 0.26 to 0.13, EBIT declined 43.91% from -$2.36M to -$3.4M, and earnings per share declined from -$0.0371 to -$0.0512.
D
Sell
4/1/2024Upgraded
ZYUS Life Sciences Corporation (ZYUS.V) was upgraded to D- from E on 4/1/2024 due to an increase in the volatility index.
E
Sell
3/27/2024Downgrade
ZYUS Life Sciences Corporation (ZYUS.V) was downgraded to E from E+ on 3/27/2024 due to a decline in the volatility index and valuation index.
E
Sell
3/12/2024Upgraded
ZYUS Life Sciences Corporation (ZYUS.V) was upgraded to E+ from E on 3/12/2024 due to an increase in the volatility index and total return index.
E
Sell
1/4/2024Upgraded
ZYUS Life Sciences Corporation (ZYUS.V) was upgraded to E from E- on 1/4/2024 due to a significant increase in the growth index and solvency index. Earnings per share increased from -$0.2297 to -$0.0448, total revenue increased 28.8% from $57.3 to $73.8, and EBIT increased 21.74% from -$3.75M to -$2.93M.
E
Sell
10/9/2023Downgrade
ZYUS Life Sciences Corporation (ZYUS.V) was downgraded to E- from E on 10/9/2023 due to a decline in the volatility index.
E
Sell
9/26/2023None
ZYUS Life Sciences Corporation (ZYUS.V) was downgraded to E from U on 09/26/2023.
